Projects per year
Personal profile
Research interests
- Exploring and understanding the key pathways involved in the development and progression of diabetic complications.
- Development of new therapeutics targeted towards the prevention and management of diabetic complications.
Research goals
The Biochemistry of Diabetes Complications Laboratory addresses important mechanistic questions across the spectrum of diabetic complications. This work is directed towards the development of novel preventive, diagnostic and therapeutic strategies through multidisciplinary approaches combining bench-top research with human physiology and clinical studies. Our work directly impacts on patient care and has been published in major journals including Circulation Research, Diabetes, Diabetes Care and Diabetologia.
Professor Merlin Thomas is an internationally recognised clinician-scientist working in the field of diabetic complications, an area of utmost importance for the health of Australians. He is trained in both nephrology and endocrinology, but is also a state-of-the-art molecular scientist. Globally, he is the third-highest ranked expert in diabetic kidney disease and recognised as an opinion leader in the field of diabetic complications. His translational research spans basic biochemistry and biology to epidemiology and clinical trials. Dr Thomas has an exceptional track record of productivity with more than 270 publications many in the highest ranked journals in his field. He is also a sought-after speaker, teacher and best-selling author, demonstrating his exceptional capability to communicate complex scientific understanding to a general audience.
As both a clinician and a scientist, Professor Thomas’ work is keenly focused on the application of his work, improving the understanding and management of diabetic complications. This work has led to the establishment of international patents as well as influencing national and international guidelines. He is CIB in the newly created NHMRC Diabetes Complications CRE. His “Biochemistry of Diabetes Complications” laboratory in the newly created Department of Diabetes at Monash University is an ideal environment for multidisciplinary research, providing a combination of intellectual and scientific expertise, high-quality infrastructure and state-of-the-art capabilities.
The principal objective of Professor Thomas' research laboratory is to advance the field of diabetes by identifying and validating novel targets towards the development of efficacious strategies for the prevention and management of diabetic complications.
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Research area keywords
- Diabetes
- Advanced Glycation End-products (AGEs)
- Atherosclerosis
- Chronic Kidney Disease (CKD)
- Diabetic Complications
- Diabetic Kidney Disease (DKD)
- Renin Angiotensin System
Collaborations and top research areas from the last five years
-
Splice switching oligonucleotides for the treatment of chronic kidney disease
Thomas, M., Wilton, S., Wraight, C., Pickering, R., Cooper, M., Coughlan, M., Tesch, G., Kitching, R. & Jupp, B.
1/01/23 → 31/12/25
Project: Research
-
Pre-clinical testing of novel inhaled RNA therapies for stability, safety and effectiveness against SARS-CoV-2 to demonstrate proof of concept
Thomas, M., McAuley, J., Wilton, S. & Pickering, R.
1/06/22 → 31/05/24
Project: Research
-
Development of an inhaled antisense oligonucleotide for the prevention and treatment of coronavirus infections
1/02/22 → 1/02/23
Project: Research
-
Inhaled oligonucleotides to generate a decoy receptor for the SARS Coronarvirus-2
Thomas, M., Wilton, S., McAuley, J. & Pickering, R.
1/06/20 → 28/02/21
Project: Research
-
Augmenting the activity of glyoxalase-1 to increase dicarbonyl clearance
1/01/20 → 31/12/22
Project: Research
-
Pyridoxamine prevents increased atherosclerosis by intermittent methylglyoxal spikes in the aortic arches of ApoE-/- mice
Hanssen, N. M. J., Tikellis, C., Pickering, R. J., Dragoljevic, D., Lee, M. K. S., Block, T., Scheijen, J. LJM., Wouters, K., Miyata, T., Cooper, M. E., Murphy, A. J., Thomas, M. C. & Schalkwijk, C. G., Feb 2023, In: Biomedicine & Pharmacotherapy. 158, 9 p., 114211.Research output: Contribution to journal › Article › Research › peer-review
Open Access -
Reduced methylation correlates with diabetic nephropathy risk in type 1 diabetes
Khurana, I., Kaipananickal, H., Maxwell, S., Birkelund, S., Syreeni, A., Forsblom, C., Okabe, J., Ziemann, M., Kaspi, A., Rafehi, H., Jørgensen, A., Al-Hasani, K., Thomas, M. C., Jiang, G., Luk, A. O., Lee, H. M., Huang, Y., Thewjitcharoen, Y., Nakasatien, S., Himathongkam, T., & 12 others , 15 Feb 2023, In: The Journal of Clinical Investigation. 133, 4, 19 p., e160959.Research output: Contribution to journal › Article › Research › peer-review
Open Access -
The postprandial actions of GLP-1 receptor agonists: The missing link for cardiovascular and kidney protection in type 2 diabetes
Thomas, M. C., Coughlan, M. T. & Cooper, M. E., 7 Feb 2023, In: Cell Metabolism. 35, 2, p. 253-273 21 p.Research output: Contribution to journal › Review Article › Research › peer-review
Open Access5 Citations (Scopus) -
Circulating Soluble ACE2 Plays an Independent Role to Protect against Vascular Damage in Diabetic Mice
Tikellis, C., Robinson, G. N., Rosado, C. J., Batu, D., Zuniga-Gutierrez, M. A., Pickering, R. J. & Thomas, M. C., May 2022, In: Antioxidants. 11, 5, 10 p., 987.Research output: Contribution to journal › Article › Research › peer-review
Open Access1 Citation (Scopus) -
The clustering of Cardiovascular, Renal, Adipo-Metabolic Eye and Liver disease with type 2 diabetes
Thomas, M. C., Mar 2022, In: Metabolism: Clinical and Experimental. 128, 6 p., 154961.Research output: Contribution to journal › Review Article › Other › peer-review
9 Citations (Scopus)